These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


644 related items for PubMed ID: 19839996

  • 1. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
    Uezato A, Meador-Woodruff JH, McCullumsmith RE.
    Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
    [Abstract] [Full Text] [Related]

  • 2. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.
    Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH.
    Neuropsychopharmacology; 2007 Sep; 32(9):1888-902. PubMed ID: 17299517
    [Abstract] [Full Text] [Related]

  • 3. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
    Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT.
    J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
    [Abstract] [Full Text] [Related]

  • 4. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression.
    Ritter LM, Meador-Woodruff JH.
    Biol Psychiatry; 1997 Aug 01; 42(3):155-64. PubMed ID: 9232207
    [Abstract] [Full Text] [Related]

  • 5. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.
    Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS.
    Mol Psychiatry; 2002 Aug 01; 7(9):985-94, 924. PubMed ID: 12399952
    [Abstract] [Full Text] [Related]

  • 6. Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.
    Oni-Orisan A, Kristiansen LV, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE.
    Biol Psychiatry; 2008 Apr 15; 63(8):766-75. PubMed ID: 18155679
    [Abstract] [Full Text] [Related]

  • 7. Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways.
    Moutsimilli L, Farley S, El Khoury MA, Chamot C, Sibarita JB, Racine V, El Mestikawy S, Mathieu F, Dumas S, Giros B, Tzavara ET.
    Neuropharmacology; 2008 Mar 15; 54(3):497-508. PubMed ID: 18155072
    [Abstract] [Full Text] [Related]

  • 8. Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy.
    van der Hel WS, Verlinde SA, Meijer DH, de Wit M, Rensen MG, van Gassen KL, van Rijen PC, van Veelen CW, de Graan PN.
    Epilepsia; 2009 Jul 15; 50(7):1717-28. PubMed ID: 19389151
    [Abstract] [Full Text] [Related]

  • 9. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
    Perlman WR, Tomaskovic-Crook E, Montague DM, Webster MJ, Rubinow DR, Kleinman JE, Weickert CS.
    Biol Psychiatry; 2005 Nov 15; 58(10):812-24. PubMed ID: 16112656
    [Abstract] [Full Text] [Related]

  • 10. Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.
    Shan D, Lucas EK, Drummond JB, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE.
    Schizophr Res; 2013 Mar 15; 144(1-3):1-8. PubMed ID: 23356950
    [Abstract] [Full Text] [Related]

  • 11. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
    Huerta I, McCullumsmith RE, Haroutunian V, Giménez-Amaya JM, Meador-Woodruff JH.
    Synapse; 2006 Jun 01; 59(7):394-402. PubMed ID: 16485262
    [Abstract] [Full Text] [Related]

  • 12. Expression of VGLUTs contributes to degeneration and acquisition of learning and memory.
    Cheng XR, Yang Y, Zhou WX, Zhang YX.
    Neurobiol Learn Mem; 2011 Mar 01; 95(3):361-75. PubMed ID: 21295146
    [Abstract] [Full Text] [Related]

  • 13. Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder.
    Medina A, Burke S, Thompson RC, Bunney W, Myers RM, Schatzberg A, Akil H, Watson SJ.
    J Psychiatr Res; 2013 Sep 01; 47(9):1150-6. PubMed ID: 23706640
    [Abstract] [Full Text] [Related]

  • 14. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
    Eastwood SL, Harrison PJ.
    Schizophr Res; 2005 Mar 01; 73(2-3):159-72. PubMed ID: 15653259
    [Abstract] [Full Text] [Related]

  • 15. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
    Pantazopoulos H, Stone D, Walsh J, Benes FM.
    Synapse; 2004 Dec 01; 54(3):147-55. PubMed ID: 15452863
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selective cortical VGLUT1 increase as a marker for antidepressant activity.
    Moutsimilli L, Farley S, Dumas S, El Mestikawy S, Giros B, Tzavara ET.
    Neuropharmacology; 2005 Nov 01; 49(6):890-900. PubMed ID: 16111724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.
    Thompson M, Weickert CS, Wyatt E, Webster MJ.
    J Psychiatr Res; 2009 Jul 01; 43(11):970-7. PubMed ID: 19321177
    [Abstract] [Full Text] [Related]

  • 20. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.
    Perlman WR, Webster MJ, Kleinman JE, Weickert CS.
    Biol Psychiatry; 2004 Dec 01; 56(11):844-52. PubMed ID: 15576061
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.